Cognitive factors in schizophrenia: Causes, impact, and treatment

被引:50
作者
Meltzer, HY [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN 37212 USA
关键词
D O I
10.1017/S1092852900025098
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Greater attention has been given to the cognitive dimension in schizophrenia in recent years. This has resulted from increased recognition that cognitive impairment and negative symptoms of the disease have a greater impact on quality of life (QOL) compared to positive symptoms. Successful treatment of Positive symptoms in patients with schizophrenia has not been shown to robustly translate into improvements in employment status or social relationships, while cognitive improvements are strongly associated with these important aspects of QOL and independence. These findings are based on extensive testing with standard cognitive tests for measuring executive function, verbal learning and memory, word recall, verbal Working memory, spatial working memory, attention, and vigilance. Verbal learning and executive function, in particular, have been found to be valid predictors of employment success independent of the degree of severity of positive symptoms.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 77 条
[31]   Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum [J].
Ichikawa, J ;
Dai, J ;
O'Laughlin, IA ;
Fowler, WL ;
Meltzer, HY .
NEUROPSYCHOPHARMACOLOGY, 2002, 26 (03) :325-339
[32]  
Javitt Daniel C, 2002, Curr Opin Investig Drugs, V3, P1067
[33]  
JOHNSTONE EC, 1976, LANCET, V2, P924
[34]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[35]   Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?:: A new hypothesis [J].
Kapur, S ;
Seeman, P .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (03) :360-369
[36]  
Kuroki T, 1999, J PHARMACOL EXP THER, V288, P774
[37]   Glutainate, dopamine, and schizophrenia - From pathophysiology to treatment [J].
Laruelle, M ;
Kegeles, LS ;
Abi-Dargham, A .
GLUTAMATE AND DISORDERS OF COGNITION AND MOTIVATION, 2003, 1003 :138-158
[38]  
LEE MA, 1994, J CLIN PSYCHIAT, V55, P82
[39]  
LIBERMAN RP, 1993, PSYCHIATRY, V56, P238
[40]  
Liberman RP, 1993, PSYCHIATRY, V56, P250